🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07327996
Active, not recruiting Not applicable

Evaluation of Pain Relief and Bacterial Reduction After Using Calcium Hydroxide With Mesoporous Silica Nanoparticles as an Intracanal Medicament in Necrotic Mandibular Molars: A Randomized Controlled Clinical Trial

NCT07327996 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2026-01-08

Condition(s) studied

Necrotic Pulp

Investigational drug(s) / intervention(s)

Calcium Hydroxide Intracanal medicationmesoporous silica nanoparticles pasteCalcium Hydroxide + mesoporous silica nanoparticles

Calcium Hydroxide Intracanal medication: root canals filled with calcium hydroxide paste as intracanal medication for 1week

mesoporous silica nanoparticles paste: root canals filled with mesoporous silica nanoparticles for 1 week

Calcium Hydroxide + mesoporous silica nanoparticles: Root canal filled with Intracanal medication by combination between mesoporous silica nanoparticles with calcium hydroxide paste for one week.

Study summary

This study compares how well different root canal medications reduce pain and bacteria after treatment of lower molar teeth with necrotic pulp. It tests whether adding mesoporous silica nanoparticles-antibacterial particles-to calcium hydroxide makes the treatment more effective. Forty-two adult patients will be randomly assigned to receive either calcium hydroxide alone, nanoparticles alone, or a mix of both for one week during root canal therapy. measure patients' pain levels after 6h,12h,24,48h and 72 hours from treatment and the number of bacteria before and after treatment to see which method gives the best results. The goal is to make root canal treatments more comfortable and successful for future patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
* Inclusion Criteria: 1. Patients with an age range between 18 to 40. 2. No sex predilection. 3. Patients with necrotic pulp. 4. Patients able to sign informed consent. 5. Restorable teeth. 6. Positive patient's acceptance for participating in the study. 7. Type III distal and mesial canal of first mandibular molar. * Exclusion Criteria: 1. Pregnant females 2. Medically compromised patients. 3. Patients having analgesics before the treatment 4. If antibiotics have been administrated during the past two weeks pre-operatively. 5. Patients having bruxism or clenching 6. Patients having sever malocclusion associated with traumatic occlusion. 7. Teeth that have: 1. Peri-apical radiolucency 2. Root resorption. 3. Pulp stones or calcifications. 4. Previous endodontic treatment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Future University in Egypt Cairo New Cairo

More Future University in Egypt trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07327996 on ClinicalTrials.gov ↗ ← All trials in Egypt